How vulnerable is Big Pharma to the predations of organized terrorist groups or that rogue malcontent with an agenda to wreak havoc on society?
Boaz Ganor
Advertisement
Articles by Boaz Ganor
Advertisement
Latest Updated Articles
Dangerous Liaisons: Terrorism and PharmaPublished: July 1st 2013 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
4
Reshaping Kidney Care: Q&A with Stylianos Sarrigiannidis
5
